Parvalbumin α (PVALB) activators encompass a range of chemical compounds that can indirectly influence the expression or function of PVALB by modulating interconnected cellular processes. PVALB is a calcium-binding protein, primarily found in certain neuronal populations and fast-contracting muscles. Its intrinsic connection to calcium homeostasis creates an avenue for chemicals that influence calcium dynamics to modulate its activity.
Calcium channel modulators, such as Nifedipine, Gabapentin, BAY K 8644, Nimodipine, Ethosuximide, Verapamil, FPL 64176, and Isradipine, play pivotal roles in adjusting calcium homeostasis. By either inhibiting or activating specific calcium channels, these compounds can alter intracellular calcium levels. Such changes in calcium concentrations can, in turn, influence PVALB's calcium-binding activity, given its primary role in calcium sequestration and buffering. Sodium and potassium channel modulators like Tetrodotoxin, 4-Aminopyridine, Tetraethylammonium, and Riluzole also form part of this class. These compounds affect neuronal excitability and firing patterns. Since PVALB is expressed in specific neuronal subsets, alterations in neuronal activity can indirectly affect PVALB expression levels. It acts as a sort of feedback mechanism, wherein the protein's expression is regulated to maintain calcium homeostasis in the face of changing neuronal activity. In essence, the chemical modulators of ion channels, by virtue of their ability to adjust neuronal and muscular ion homeostasis, can have downstream effects on proteins like PVALB that are intrinsically tied to these processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
A calcium channel blocker that affects calcium homeostasis. By modulating calcium levels, it can influence PVALB's calcium-binding activity. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
An activator of L-type calcium channels, potentially affecting PVALB through modulation of calcium homeostasis. | ||||||
4-Aminopyridine | 504-24-5 | sc-202421 sc-202421B sc-202421A | 25 g 1 kg 100 g | $38.00 $1155.00 $122.00 | 3 | |
Potassium channel blocker that affects neuronal excitability. Altered neuronal activity can influence PVALB expression. | ||||||
Ethosuximide | 77-67-8 | sc-211431 | 1 g | $306.00 | ||
Impacts T-type calcium channels, influencing calcium homeostasis and potentially PVALB's function. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
A calcium channel blocker, influencing calcium levels and potentially affecting PVALB activity. | ||||||
FPL-64176 | 120934-96-5 | sc-201491 | 5 mg | $83.00 | 1 | |
L-type calcium channel agonist. By modulating calcium levels, it can influence PVALB function. | ||||||
Isradipine | 75695-93-1 | sc-201467 sc-201467A | 10 mg 50 mg | $88.00 $324.00 | 1 | |
Another calcium channel blocker, impacting calcium homeostasis and potentially influencing PVALB. | ||||||
Riluzole | 1744-22-5 | sc-201081 sc-201081A sc-201081B sc-201081C | 20 mg 100 mg 1 g 25 g | $20.00 $193.00 $213.00 $317.00 | 1 | |
Modulates sodium channels and glutamatergic transmission. Its effect on neuronal activity can influence proteins like PVALB. | ||||||